Device type · CHH
Enzymatic Esterase--Oxidase, Cholesterol
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CHH
Clinical Chemistry
Device class
Class I
FDA decisions since 2015
9
510(k), De Novo and PMA
Adverse event reports
23
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Enzymatic Esterase--Oxidase, Cholesterol
- Product code
- CHH
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1175
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CHH
Latest FDA decisions
The 8 newest of 9 since 2015.
- Lipids510(k)
K251091 · Decided Dec 30, 2025 · 264 days after receipt
Device type: Enzymatic Esterase--Oxidase, Cholesterol (CHH) · Laboratory Medicine & Pathology
K232404 · Decided Aug 9, 2024 · 365 days after receipt
Device type: Enzymatic Esterase--Oxidase, Cholesterol (CHH) · Laboratory Medicine & Pathology
- Cholesterol2510(k)
Abbott Ireland Diagnostics Division
K203597 · Decided Jun 30, 2022 · 568 days after receipt
Device type: Enzymatic Esterase--Oxidase, Cholesterol (CHH) · Laboratory Medicine & Pathology
6 more FDA decisions with a free account
Reports received
23
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
23
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 3 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 3 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 2 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 2 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 3 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 3 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 4 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 1 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Non Reproducible Results10
- High Test Results7
- Incorrect Measurement4
2 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions23
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- QUCARE Total Cholesterol in vitro diagnostic test REF: 6407Open, Classified
Z-2085-2026 · Started Apr 2, 2026 · Posted by FDA May 6, 2026
Reason given: The devices were distributed without required FDA premarket clearance or approval.
Cause as FDA categorized it: No Marketing Application
Z-1424-2022 · Started Jun 22, 2022
Reason given: Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the...
Cause as FDA categorized it: Process design
- SYNCHRON Systems Cholesterol (CHOL) Reagent, REF: 467825Open, Classified
Z-0399-2022 · Started Nov 10, 2021
Reason given: Cholesterol Reagent may fail with Out of Calibration Range Low (OCR Low) and/or Back to Back (B/B) errors. Low quality control recovery failures may be observed after passing calibration. Brown particulates in compartment C of the reagent cartridge may be observed. Continued use may lead to, 1) failed QC and/or...
Cause as FDA categorized it: Nonconforming Material/Component
20 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.